Literature DB >> 7813334

Evaluation of flow cytometric methods for diagnosis of chronic granulomatous disease variants under routine laboratory conditions.

A Emmendörffer1, M Nakamura, G Rothe, K Spiekermann, M L Lohmann-Matthes, J Roesler.   

Abstract

Neutrophils from 50 pediatric patients with normal phagocyte functions, from 150 healthy adults, from 10 chronic granulomatous disease (CGD)-patients (4 CGD+), and from 18 X-linked carriers for CGD have been tested for their production of H2O2 using staining with dihydrorhodamine 123 and subsequent flow cytometry. Additionally, neutrophils from three patients with myeloperoxidase deficiency were assessed. Cells were activated to produce H2O2 by the phorbol ester phorbol-myristate-acetate (PMA) and by phagocytosis of Escherichia coli bacteria. To evaluate the sensitivity of the method, H2O2-production by neutrophils which was inhibited by different concentrations of diphenyljodonium (DPI) was measured. The results were compared to those from other methods (NBT-testing, cytochrome c-reduction, and especially chemiluminescence). Normal values and ranges of scatter profile were evaluated in terms of peak channel fluorescence: 97% > 700, x = 840 +/- 59 (S.D.), 97% < 890, for pediatric patients. Normal quantitative values also resulted from small blood samples of infants (< 1 year, n = 6, x = 830 +/- 52). For CGD+ (n = 4) the results were clearly far below the normal range. In indicating decreased production of reactive oxygen intermediates the method was at least as sensitive as lucigenin enhanced chemiluminescence. Cytochrome b558-expression of neutrophils from patients and healthy controls was established by flow cytometry following staining with the monoclonal antibody 7D5. The normal range was 97% > 485, 97% < 680, peak channel fluorescence. We conclude that flow cytometric routine diagnostics of CGD can easily enhance the reliability of recognition and the yield of information about this disease compared to conventional methods.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7813334     DOI: 10.1002/cyto.990180306

Source DB:  PubMed          Journal:  Cytometry        ISSN: 0196-4763


  10 in total

Review 1.  Molecular diagnosis of chronic granulomatous disease.

Authors:  D Roos; M de Boer
Journal:  Clin Exp Immunol       Date:  2014-02       Impact factor: 4.330

2.  Critical roles for p22phox in the structural maturation and subcellular targeting of Nox3.

Authors:  Yoko Nakano; Botond Banfi; Algirdas J Jesaitis; Mary C Dinauer; Lee-Ann H Allen; William M Nauseef
Journal:  Biochem J       Date:  2007-04-01       Impact factor: 3.857

3.  A new pathway of staphylococcal pathogenesis: apoptosis-like death induced by Staphopain B in human neutrophils and monocytes.

Authors:  Jan Smagur; Krzysztof Guzik; Lukasz Magiera; Malgorzata Bzowska; Milosz Gruca; Ida B Thøgersen; Jan J Enghild; Jan Potempa
Journal:  J Innate Immun       Date:  2008-12-02       Impact factor: 7.349

Review 4.  Clinical manifestations of disease in X-linked carriers of chronic granulomatous disease.

Authors:  A C Battersby; A M Cale; D Goldblatt; A R Gennery
Journal:  J Clin Immunol       Date:  2013-11       Impact factor: 8.317

5.  Comparative study of neutrophil activation by chemiluminescence and flow cytometry.

Authors:  M M Lieberman; D M Sachanandani; C A Pinney
Journal:  Clin Diagn Lab Immunol       Date:  1996-11

6.  Rapid whole-blood flow cytometry assay for diagnosis of chronic granulomatous disease.

Authors:  M R O'Gorman; V Corrochano
Journal:  Clin Diagn Lab Immunol       Date:  1995-03

7.  Flow cytometric evaluation of leukocyte function in rat whole blood.

Authors:  Wen Li; S C Sydney Chung
Journal:  In Vitro Cell Dev Biol Anim       Date:  2003 Nov-Dec       Impact factor: 2.416

8.  X-linked chronic granulomatous disease secondary to skewed X chromosome inactivation in a female with a novel CYBB mutation and late presentation.

Authors:  Eric M Lewis; Manav Singla; Susan Sergeant; Patrick P Koty; Linda C McPhail
Journal:  Clin Immunol       Date:  2008-09-06       Impact factor: 3.969

9.  Chronic granulomatous disease: a review of the infectious and inflammatory complications.

Authors:  Eunkyung Song; Gayatri Bala Jaishankar; Hana Saleh; Warit Jithpratuck; Ryan Sahni; Guha Krishnaswamy
Journal:  Clin Mol Allergy       Date:  2011-05-31

10.  Chronic granulomatous disease: the European experience.

Authors:  J Merlijn van den Berg; Elsbeth van Koppen; Anders Ahlin; Bernd H Belohradsky; Ewa Bernatowska; Lucien Corbeel; Teresa Español; Alain Fischer; Magdalena Kurenko-Deptuch; Richard Mouy; Theoni Petropoulou; Joachim Roesler; Reinhard Seger; Marie-José Stasia; Niels H Valerius; Ron S Weening; Baruch Wolach; Dirk Roos; Taco W Kuijpers
Journal:  PLoS One       Date:  2009-04-21       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.